References
- 1..Ren J,Song M,Zhang W,Cai JP,Cao F,Cao Z, et al. The aging biomarker consortium represents a new era for aging research in China. Nat Med.2023;29(9):2162-5.
- 2..Sung H,Ferlay J,Siegel RL,Laversanne M,Soerjomataram I,Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin.2021;71(3):209-49.
- 3..Zi H,Liu MY,Luo LS,Huang Q,Luo PC,Luan HH, et al. Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021. Mil Med Res. 2024;11(1):64.
- 4..GBD 2021 Diseases and Injuries Collaborators. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations,1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet. 2024; 403(10440):2133-61.
- 5..Cao F,He YS,Wang Y,Zha CK,Lu JM,Tao LM, et al. Global burden and cross-country inequalities in autoimmune diseases from 1990 to 2019. Autoimmun Rev. 2023;22(6):103326.

